ROSUVIB F 10/145 ROSUVASTATIN 10mg. IP + FENOFIBRATE 145mg. IP

Rosuvib F 10/145 tablets combine Rosuvastatin and Fenofibrate to manage raised cholesterol and triglycerides in adults. Main uses: adjunct to diet to reduce elevated LDL cholesterol, total cholesterol, triglycerides and apolipoprotein B in adults with primary hypercholesterolemia or mixed dyslipidemia; adjunct to diet to increase HDL cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia; adjunct to diet for the treatment of adults with severe hypertriglyceridemia; adjunct to diet to lower LDL cholesterol and triglycerides and to improve the overall lipid profile in adults with mixed dyslipidemia.

Common side effects of Rosuvib F 10/145 Tablet include headache; nausea; muscle pain (myalgia); weakness or tiredness (asthenia); constipation; abnormal liver test results (raised AST or ALT). Get medical help at once if you notice myopathy and rhabdomyolysis, mainly when used with a statin, especially in elderly, diabetic, kidney-impaired or hypothyroid patients; liver injury (hepatotoxicity), including serious drug-induced liver injury; gallstones (cholelithiasis) and pancreatitis.

Each Rosuvib F 10/145 tablet contains Rosuvastatin 10 mg + Fenofibrate 145 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Rosuvib F 10/145 Tablet only as your doctor advises.

The MRP of Rosuvib F 10/145 Tablet is ₹179 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹136.38 and the PTS is ₹122.74.

Each Rosuvib F 10/145 tablet contains Rosuvastatin 10 mg + Fenofibrate 145 mg. It comes in a pack of 10x10 (Alu Alu).

Rosuvastatin stops the liver enzyme HMG-CoA reductase from making cholesterol, which lowers LDL cholesterol in the blood. Fenofibrate works through PPAR-alpha activation to speed the breakdown and clearance of triglyceride-rich particles and to raise HDL cholesterol. Taking fenofibrate along with a statin increases the risk of muscle problems (myopathy and rhabdomyolysis), so any unexplained muscle pain, tenderness or weakness must be reported to the doctor at once.

Must not be used by patients with acute liver failure or decompensated cirrhosis or any active liver disease. Must not be used by patients with severe renal impairment, including those on dialysis. Must not be used by patients with pre-existing gallbladder disease. Must not be used by nursing mothers. Must not be used by patients with known hypersensitivity to rosuvastatin, fenofibrate or any ingredient of the tablet; check with a doctor first if you are elderly, have kidney problems, uncontrolled hypothyroidism, diabetes, or take coumarin anticoagulants, and report any unexplained muscle pain or weakness at once.

Rosuvib F 10/145 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.